Epinephrine inhibits endotoxin-induced IL-1β production: Roles of tumor necrosis factor-α and IL-10

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 273, Issue 6 42-6, 1997, Pages

  Van Poll, Tom Der ^a,b   Lowry, Stephen F ^a,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Adenosine 3',5' cyclic monophosphate; Adrenergic receptors; Cytokines; Interleukin 1 ; Interleukin 10; Lipopolysaccharide

Indexed keywords

ADRENALIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; DOSE RESPONSE; ENDOTOXEMIA; HORMONAL REGULATION; HOST RESISTANCE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION;

EID: 0031414266     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1997.273.6.r1885     Document Type: Article

References (22)

1. Bailly, S., B. Ferrua, M. Fay, and M. A. Gougerot-Pocidalo. Differential regulation of IL-6, IL-1α, IL-1β and TNFα production in LPS-stimulated monocytes: role of cyclic AMP. Cytokine 2: 205-210, 1990.
2. Casey, L. C., R. A. Balk, and R. C. Bone. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119: 771-778, 1993.
3. Cassatella, M. A. The production of cytokines by polymorphonuclear neutrophils. Immunol. Today 16: 21-23, 1995.
4. de Grootte, D., P. F. Zangerle, Y. Gevaert, M. F. Fassotte, Y. Beguin, F. Noizat-Pirenne, J. Pirenne, R. Gathy, M. Lopez, I. Dehart, D. Igot, M. Baudrihaye, D. Delacroix, and P. Franchimont. Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN- and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 4: 239-248, 1992.
5. de Waal Malefyt, R., J. Abrams, B. Bennett, C. Figdor, and J. E. de Vries. IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209-1220, 1991.
6. Dinarello, C. A. Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147, 1996.
7. Fieren, M. W. J. A., G. J. C. M. van den Bemd, S. Ben-Efraim, and L. L. Bonta. Prostaglandin E2 inhibits the release of tumor necrosis factor-α rather than interleukin 1β, from human macrophages. Immunol. Lett. 31: 85-90, 1991.
8. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147: 3815-3822, 1991.
9. Fischer, E., M. A. Marano, A. E. Barber, A. Hudson, K. Lee, C. S. Rock, A. S. Hawes, R. C. Thompson, T. J. Hayes, T. D. Anderson, W. R. Benjamin, S. F. Lowry, and L. L. Moldawer. Comparison between effects of interleukin-1α administration and sublethal endotoxemia in primates. Am. J. Physiol. 261 (Regulatory Integrative Comp. Physiol. 30): R442-R452, 1991.
10. Fischer, E., M. A. Marano, K. J. van Zee, C. S. Rock, A. S. Hawes, W. A. Thompson, L. DeForge, J. S. Kenney, D. G. Remick, D. C. Bloedow, R. C. Thompson, S. F. Lowry, and L. L. Moldawer. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J. Clin. Invest. 89: 1551-1557, 1992.
11. Fong, Y., K. J. Tracey, L. L. Moldawer, D. G. Hesse, K. R. Manogue, J. S. Kenney, A. T. Lee, G. C. Kuo, A. C. Allison, S. F. Lowry, and A. Cerami. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1β and interleukin 6 appearance during lethal bacteremia. J. Exp. Med. 170: 1627-1633, 1989.
12. Frayn, K. N. Hormonal control of metabolism in trauma and sepsis. Clin. Endocrinol. (Oxf.) 24: 577-599, 1986.
13. Girardin, E., G. E. Grau, J. M. Dayer, P. Roux-Lombard, the J5 study group, and P. H. Lambert. Tumor necrosis factor and interleukin 1 in the serum of children with severe infectious purpura. N. Engl. J. Med. 319: 397-400, 1988.
14. Haskill, S., C. Johnson, D. Eierman, S. Becker, and K. Warren. Adherence induces selective mRNA expression of monocyte mediators and protooncogenes. J. Immunol. 140: 1690-1694, 1988.
15. Hollenberg, S. M., and J. E. Parillo. Pharmacologic circulatory support. In: Surgical Intensive Care, edited by P. S. Barie and G. T. Shires. Boston, MA: Little, Brown, 1993, p. 417-451.
16. Hurme, M. Modulation of interleukin-1β production by cyclic AMP in human monocytes. FEBS Lett. 263: 35-37, 1990.
17. Hurme, M., E. Serkkola, T. Ronni, and O. Silvennoien. Control of interleukin-1β expression by protein kinase C and cyclic adenosine monophosphate in myeloid leukemia cells. Blood 76: 2198-2203, 1990.
18. Kenney, J. S., M. P. Masada, E. M. Eugui, B. M. Delustro, M. A. Mulkins, and A. C. Allison. Monoclonal antibodies to human recombinant interleukin 1 (IL-1)beta: quantitation of IL-1beta and inhibition of biological activity. J. Immunol. 138: 4236-4242, 1987.
19. Monastra, G., and E. F. Secchi. β-Adrenergic receptors mediate in vivo the adrenaline inhibition of lipopolysaccharide-induced tumor necrosis factor release. Immunol. Lett. 38: 127-130, 1993.
20. Ogilvie, A. C., C. E. Hack, J. Wagstaff, G. J. van Mierlo, A. J. M. Eerenberg, L. L. Thomsen, K. Hoekman, and E. M. Rankin. IL-1β does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancer. Blood 156: 389-394, 1996.
21. Ohlsson, K., P. Björk, M. Bergenfeldt, R. Hageman, and R. C. Thompson. Interleukin 1 receptor antagonist reduces mortality from endotoxin shock. Nature 348: 550-552, 1990.
22. Ohmori, Y., G. Strassman, and T. A. Hamilton. cAMP differentially regulates expression of mRNA encoding IL-1α and IL-1β in murine peritoneal macrophages. J. Immunol. 145: 3333-3339, 1990.